Skip to main content
Psyence Group Inc. logo

Psyence Group Inc. — Investor Relations & Filings

Ticker · PSYG ISIN · CA74449Q2053 LEI · 549300RPEOIVSD0MJC07 CSE Manufacturing
Open in API
Filings indexed 387 across all filing types
Latest filing 2022-01-06 Regulatory Filings
Country CA Canada
Listing CSE PSYG

About Psyence Group Inc.

https://psyence.com/

Psyence Group Inc. is a science-led life science biotechnology company focused on the research, cultivation, and production of natural psychedelics and nature-based compounds. The company develops innovative, safe, and effective solutions for mental health. Its core clinical division, Psyence Therapeutics (now part of Psyence Biomedical Ltd.), pioneers the use of natural psilocybin formulations and treatment protocols, primarily targeting anxiety and depression within the context of palliative care. Supporting this effort, the company operates one of the world's first federally licensed, ISO22000 certified psilocybin cultivation and production facilities. Furthermore, Psyence Function markets a range of non-psychoactive functional mushroom wellness products utilizing adaptogens.

Recent filings

Filing Released Lang Actions
Other securityholders documents - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Restricted Share Unit Plan of Psyence Group Inc.' and contains detailed provisions, definitions, and rules related to a restricted share unit (RSU) plan. It includes terms about the establishment, purpose, administration, and definitions relevant to the RSU plan. There is no indication that this is an announcement or summary of a report, nor does it contain financial statements or earnings data. It is a formal plan document related to equity compensation, which is a form of security-based compensation arrangement. Such documents typically fall under governance or remuneration-related filings. However, since this document specifically details the terms and administration of a share unit plan, it is best classified under Regulatory Filings (RNS) as it does not fit the more specific categories like Remuneration Information (DEF 14A) which usually focus on compensation tables and executive pay disclosures, nor is it a proxy solicitation or shareholder meeting material. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-01-06 English
Other securityholders documents - English.pdf
Governance Information Classification · 100% confidence The document is titled 'BY-LAW NO. 1, AS AMENDED AND RESTATED' and contains detailed provisions about the corporation's governance, including sections on interpretation, business of the corporation, borrowing and security, directors, committees, officers, protection of directors and officers, shares, dividends, meetings of shareholders, notices, and effective date. The content is focused on the internal rules and governance structure of the company rather than financial performance, audit results, or shareholder meeting materials. There is no indication that this is an annual report, earnings release, or any other financial report. Instead, it is a governance document outlining the company's by-laws. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-01-06 English
Other.pdf
Regulatory Filings
2021-12-07 English
News release - English.pdf
Regulatory Filings
2021-12-03 English
News release - English.pdf
Regulatory Filings
2021-12-02 English
News release - English.pdf
Regulatory Filings
2021-12-02 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.